Encorium signs $3.8 million contract for shingles clinical trial

Encorium will provide multiple services including program consulting, project management, site management and monitoring, data management, biostatistical support, and medical writing.

Revenue recognition will begin during the current second quarter and continue on a proportional performance basis over the life of the contract as services are performed.

Encorium says the trial will combine its previous infectious disease therapeutic area experience and clinical operation capabilities gained from overseeing a 38,546 subject shingles prevention trial and patient recruitment from clinical trials relating to antiviral treatments for acute influenza.